Epoprostenol for Injection (EFI/ACT-385781A) - Pulmonary Arterial Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

July 31, 2012

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

EFI/ACT-385781A

Trial Locations (8)

3000

UZ Gasthuisberg, Leuven

8035

Hospital Vall d'Hebron, Barcelona

14033

Centre Hospitalier Universitaire, Caen

40138

Orsola Malpighi, Bologna

92141

Hôpital Antoine Béclère, Clamart

M5G 2N2

University Health Network, Toronto TGH - 10 EN - 220, Toronto

H3T 1 E2

Sir Mortimer B Davis Jewish General Hospital, Montreal

1081 HV

VU Medisch Centrum (VUMC), Amsterdam

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY